Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
BHVN Price and Sentiment
BHVN Latest news
Biohaven (BHVN) Misses on Q3 Earnings, Inks $1.24B Pfizer Deal
2021-11-10 11:28Biohaven's (BHVN) sole approved drug, Nurtec ODT, for treating migraine, continues to demonstrate strong demand in the United States. The company signs an agreement with Pfizer, granting the latter ex-U.S. marketing rights to Nurtec ODT.
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) CEO Vlad Coric on Q3 2021 Results - Earnings Call Transcript
2021-11-09 13:08Biohaven Pharmaceutical Holding Company Ltd. (BHVN) CEO Vlad Coric on Q3 2021 Results - Earnings Call Transcript
Pfizer Gains Outside US Rights To Biohaven's Migraine Treatment For $500M
2021-11-09 10:49Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) and Pfizer Inc (NYSE: PFE) have announced an agreement for rimegepant in markets outside the U.S. Rimegepant is commercialized as Nurtec ODT in the U.S. and is indicated for the acute treatment of migraine attacks with or without aura and the preventive treatment of episodic migraine in adults.
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q3 Loss, Tops Revenue Estimates
2021-11-09 10:43Biohaven Pharmaceutical Holding Company Ltd. (BHVN) delivered earnings and revenue surprises of -7.79% and 1.45%, respectively, for the quarter ended September 2021.
Biohaven's stock slides 15% on deal with Pfizer for its migraine drug
2021-11-09 08:07Shares of Biohaven Pharmaceutical Holding Company Ltd. BHVN, -4.29% tumbled 15.2% in premarket trading on Tuesday after it announced a deal worth up to $1.2 billion with Pfizer Inc. PFE, -0.58% to commercialize the company's migraine treatment outside of the U.S. Pfizer's stock was down 0.4% in trading before the market opened on Tuesday.
Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
2021-11-09 07:46NEW HAVEN, Conn. and NEW YORK, Nov. 9, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Reports Third Quarter 2021 Financial Results And Recent Business Developments
2021-11-09 07:45NEW HAVEN, Conn., Nov. 9, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd.
Biohaven To Report Third Quarter 2021 Financial Results And Recent Business Developments On November 9, 2021
2021-11-04 07:30NEW HAVEN, Conn., Nov. 4, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd.
Nine Line Apparel and Biohaven's Nurtec ODT Set to Honor World War II Veterans Ahead of 80th Anniversary at Phoenix Raceway
2021-11-02 07:30MOORESVILLE, N.C., Nov. 2, 2021 /PRNewswire/ -- Rick Ware Racing (RWR) has joined forces once again with Nine Line Apparel and Biohaven Pharmaceuticals' Nurtec® ODT (rimegepant) to pay tribute and honor the upcoming 80th Anniversary of the Attack on Pearl Harbor this weekend at Phoenix Raceway for the season finale.
Will Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Report Negative Q3 Earnings?
2021-11-01 16:06Biohaven Pharmaceutical Holding Company Ltd. (BHVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.